Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Valeureux is a venture capital fund based in Paris, France, established to support early-stage deep tech companies. The firm focuses on innovative ventures that address significant challenges in health, climate, and biodiversity. Valeureux aims to identify and nurture promising technologies at the research stage, preparing them for subsequent funding rounds.
The organization emphasizes long-term partnerships, providing support from inception through to full potential. Although specific metrics such as fund size and total portfolio count are not disclosed, Valeureux is committed to fostering impactful ventures in the European market.
Valeureux invests primarily in early deep tech companies, particularly those that offer disruptive solutions to major global issues. The firm targets sectors including frontier technology, healthcare, and climate. Their investment strategy is centered on identifying promising technologies at the research stage and preparing them for future funding rounds.
Investment stages include pre-seed, seed, and seed-plus (extension). Valeureux seeks to build long-term partnerships with founders, supporting them throughout their journey. The firm values innovative approaches and impactful solutions, making it an attractive partner for startups in these sectors.
Valeureux's portfolio includes notable companies that exemplify its investment strategy. One highlighted success is CXS Therapeutics, recognized for its innovative contributions in the healthcare sector. This company showcases Valeureux's commitment to supporting ventures that tackle significant challenges.
While specific details about additional portfolio companies are not provided, Valeureux's focus on deep tech suggests a diverse range of investments within the sectors of health, climate, and frontier technology.
Philippe Nussbaumer - General Partner, brings extensive experience in venture capital and deep tech investments.
Claudio Disma - VC Analyst, specializes in evaluating early-stage technology companies.
Brunetto Santolin - VC Analyst, focuses on market analysis and investment opportunities in deep tech.
Célestine Falise - Market Approach and Sales, responsible for developing market strategies for portfolio companies.
Béatrice Vivier - Director of M&A, oversees mergers and acquisitions within the portfolio.
Gaspard de Monclin - Business Lawyer, provides legal support for investment transactions.
Annie-Claude Benichou - Clinical Trials, offers expertise in clinical research and regulatory affairs.
Laurent Meilhac - Laser Optics and Medical Devices, specializes in technology related to medical devices.
Daphnée Lucenet - Engineering Sciences and Innovative Models, focuses on engineering solutions for deep tech applications.
Matthieu Peterschmitt - Electronics and Energy Economics, provides insights into energy-efficient technologies.
To pitch Valeureux, founders should visit their website at valeureux.com. A clear and concise pitch deck that outlines the technology, market opportunity, and team is recommended. Specific response time expectations are not provided.
Valeureux has been actively promoting its investment strategy and portfolio through its website, highlighting its commitment to early deep tech investments. The firm features CXS Therapeutics as a notable success in its portfolio, indicating ongoing engagement with impactful ventures.
Recent activities include the emphasis on long-term partnerships and support for companies from inception to full potential, aligning with their investment thesis.
What are Valeureux's investment criteria?
Valeureux focuses on early-stage deep tech companies that provide disruptive solutions to major issues in health, climate, and biodiversity. They look for innovative technologies at the research stage.
How can I pitch to Valeureux?
Interested parties can submit their pitches through Valeureux's website at valeureux.com. Specific email addresses for direct contact are not provided.
What makes Valeureux different from other investors?
Valeureux emphasizes long-term partnerships, supporting companies from inception to full potential. Their focus on deep tech and disruptive solutions sets them apart in the investment landscape.
What is Valeureux's geographic focus?
The firm primarily invests in Europe, with a strong emphasis on the French market.
What stages does Valeureux invest in?
Valeureux invests at the pre-seed, seed, and seed-plus (extension) stages, targeting early-stage companies with high growth potential.
What type of support does Valeureux provide post-investment?
Valeureux supports its portfolio companies through mentorship, operational guidance, and access to a network of experts in various fields, including clinical trials and engineering sciences.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.